Diosgenin caproate Uses, Dosage, Side Effects and more
Diosgenin caproate (SP-233) is the first drug ever to demonstrate the correlation of clearing beta-amyloid from the brain. It also improves the brain histopathology and recovers memory function.
| Attribute | Details |
|---|---|
| Trade Name | Diosgenin caproate |
| Generic | Caprospinol |
| Caprospinol Other Names | Diosgenin caproate |
| Type | |
| Formula | C33H52O4 |
| Weight | Average: 512.775 Monoisotopic: 512.386560154 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Alzheimer's Disease
How Diosgenin caproate works
Diosgenin caproate cleared beta-amyloid plaque formation and restored memory capacity in-vivo; confirming in-vitro studies showing Diosgenin caproate binds ß-amyloid directly and inhibits the formation of neurotoxic amyloid-derived diffusible ligands (ADDLs) by forming stable heavy complexes with the peptide. In addition, the studies demonstrated Diosgenin caproate protects mitochondria function, thus protecting cell viability and decreased cell death.
